X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

期刊標題檢索 J CELL MOL MED 最新評論: Submitted on February 9, 2024, the manuscript was sent for external ... (2024-05-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CELLULAR AND MOLECULAR MEDICINE]您好,您是該頁面的第 16366 位訪客。

期刊簡介
期刊名稱JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LetPub Score
7.1
50 ratings
Rate

Reputation
8.3

Influence
6.1

Speed
7.1

期刊簡稱J CELL MOL MED
ISSN1582-4934
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.501.2070.917
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q127 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q146 / 285

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches.
官方網站https://onlinelibrary.wiley.com/journal/15824934
在線稿件提交https://mc.manuscriptcentral.com/jcmm
開放訪問Yes
出版商Wiley-Blackwell
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區United Kingdom
發行頻率
創刊年0
每年文章數403每年文章數趨勢
黃金OA百分比65.76%
OA Related Info
APC: Yes( USD4510; GBP2920; EUR4180; )
APC waiver:Check Notes
Other charges: No
Keywords: cellular medicine、molecular medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ281/205
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ258/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1582-4934%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 28 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【JOURNAL OF CELLULAR AND MOLECULAR MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal for ImmunoTherapy of CancerH-index: 36

    CiteScore: 17.70
    Biomarker ResearchH-index: 0

    CiteScore: 15.80
    Cell Chemical BiologyH-index: 166

    CiteScore: 14.70
    Molecular BiomedicineH-index: 0

    CiteScore: 6.30
    Molecular OncologyH-index: 63

    CiteScore: 12.60
    VIROLOGICA SINICAH-index: 20

    CiteScore: 9.30
    Biotechnology JournalH-index: 70

    CiteScore: 8.90
    Frontiers in GeneticsH-index: 61

    CiteScore: 5.50
    Pharmacogenomics & Personalized MedicineH-index: 0

    CiteScore: 3.30
    Advances in Biological RegulationH-index: 0

    CiteScore: 8.90
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics332851
    Cell Chemical Biology78160
    Journal for ImmunoTherapy of Cancer76041
    Biotechnology Journal44109
    VIROLOGICA SINICA40948
    Biomarker Research37393
    Molecular Oncology31144
    Pharmacogenomics & Personalized Medicine15095
    Molecular Biomedicine7009
    Exploration of Medicine4037
  •  

    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/48)
  [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論撰寫評論
作者: dufanpan


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-30 16:09:18 評論於
Submitted on February 9, 2024, the manuscript was sent for external review by the editor after about a week. The external review took about half a month, with major revisions requested on March 4. Two months were given for revisions, and the revised manuscript was resubmitted on May 2. It entered the review process on May 3, awaiting the editor's recommendation on May 22, and the editor-in-chief's decision on May 27. The manuscript was accepted on May 28 (accepted on the same day as the peer defense, sharing the joy).

The journal editor provided insightful comments and the review process was detailed with many targeted suggestions. Each reviewer's comment was addressed in the revisions, resulting in a successful acceptance of the paper. Congratulations to everyone whose articles were accepted!
(0) 讚! | dufanpan

作者: Duncan Sharp


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 21:19:48 評論於
I also submitted in November and they have been saying they are still looking for reviewers, so I haven't received any feedback yet
(0) 讚! | Duncan Sharp

作者: 仙灵半菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 17:19:14 評論於
After receiving the article, in addition to the $4510 APC, are there any color charges?
(0) 讚! | 仙灵半菡

作者: 韶阳君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 20:36:17 評論於
Excuse me, what's happening now? Are we going back during the renovation?
(0) 讚! | 韶阳君

作者: 韶阳君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 16:49:26 評論於
Is it so unimaginable?
(0) 讚! | 韶阳君

作者: 通幽韵梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-05 16:58:18 評論於
Review speed: 12.0 | Submission acceptance rate: 50.0
Experience sharing: Very slow, submitted in September last year, just accepted on Labor Day
(0) 讚! | 通幽韵梅

作者: Duncan Sharp


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-05 10:39:13 評論於
So slow, so slow. My article has been waiting for reviewers' comments for over five months now
(0) 讚! | Duncan Sharp

作者: 仙灵半菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-11 08:32:35 評論於
How is the article going now? Mine has been UR since the end of December 23, and I'm not sure how much longer it will take
(0) 讚! | 仙灵半菡

作者: 明冠芳林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 13:05:41 評論於
I am also in this situation, have you submitted it for external review?
(0) 讚! | 明冠芳林

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 22:47:47 評論於
Thank you
(0) 讚! | 璃沙癸巳

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 21:54:12 評論於
Thank you for your insights, my feedback has been revised and given the opportunity for modification
(0) 讚! | 璃沙癸巳

作者: 烈焰香露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 23:19:56 評論於
It has already been audited
(0) 讚! | 烈焰香露

作者: 烈焰香露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 22:28:50 評論於
Our editor is the same person. Experience sharing: Submitted in the beginning of October 23rd; Received first round of comments in early February 24th, major revisions, two reviewers, feedback was quite positive; Revised by the end of February 24th; Returned to editor in mid-March 24th, editor took around 10 days to review, received acceptance email on March 25th. Personally feel that both reviewers and editor are fair, no discrimination. Just took 5 and a half months. If in a hurry to publish, do not choose this journal
(0) 讚! | 烈焰香露

作者: 烈焰香露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 18:21:31 評論於
Ten days
(0) 讚! | 烈焰香露

作者: 烈焰香露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 15:11:58 評論於
10 days
(0) 讚! | 烈焰香露

作者: 烈焰香露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 11:23:12 評論於
First-instance opinions issued in four months
(0) 讚! | 烈焰香露

作者: 终幕兰若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-20 08:31:59 評論於
I also don't know if this is a niche project. It's been two weeks since submitting for review, but there has been no response for two months
(0) 讚! | 终幕兰若

作者: 纳尔逊斯特朗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 19:11:30 評論於
It has been 4 months since we met
(0) 讚! | 纳尔逊斯特朗

作者: 月河莉霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-11 23:20:48 評論於
This is an external audit
(0) 讚! | 月河莉霞

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-10 12:45:07 評論於
Brother, I am just like you. May I ask if this status has been sent for external review?
(0) 讚! | 璃沙癸巳

作者: 西风泰河


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-06 18:49:05 評論於
You are so fast, I have been waiting all along
(0) 讚! | 西风泰河

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-01 15:34:02 評論於
Research focus: Tumor experience sharing: May I ask if "ADM: Natesan, Jayashree - Under Review" in the system means it is under external review? It has been in this status for over a month, should I send an email to follow up?
(0) 讚! | 璃沙癸巳

作者: 寻冬君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 12:38:58 評論於
Excuse me, how are things going now?
(0) 讚! | 寻冬君

作者: 西风泰河


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-26 15:13:00 評論於
Submitted on 24.02.20, now still waiting for the process
(0) 讚! | 西风泰河

作者: 月河莉霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-24 11:31:32 評論於
A month and a half
(0) 讚! | 月河莉霞

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/48)

開始撰寫 [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*